Plain-English translation of NCT07493551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a new version of paliperidone palmitate injection—a long-acting medication given once every three months—works just as well as the existing version for people with schizophrenia. Researchers are comparing how the two versions behave in your body to make sure they're equally effective and safe.
This medication helps many people manage schizophrenia symptoms, but having multiple versions from different manufacturers means doctors need to confirm they all perform the same way. This study ensures that patients can access the treatment reliably and safely, regardless of which manufacturer's version they receive.
You likely qualify if…
You likely don't qualify if…
You would receive injections of the medication at multiple visits over several months, with the study comparing how your body processes the new version versus the standard version. You'll have blood tests and clinical assessments to monitor how well the medication is working and check for any side effects. The study takes place across multiple centers in China and involves regular check-ins with the research team.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China